Cargando…
Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer
Triple‐negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and conventional chemotherapy and molecular‐targeted therapies show limited efficacy. Near‐infrared photoimmunotherapy (NIR‐PIT) is a new anticancer treatment that selectively damages the cell membrane of cancer ce...
Autores principales: | Fukushima, Hiroshi, Kato, Takuya, Furusawa, Aki, Okada, Ryuhei, Wakiyama, Hiroaki, Furumoto, Hideyuki, Okuyama, Shuhei, Kondo, Eisaku, Choyke, Peter L., Kobayashi, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459244/ https://www.ncbi.nlm.nih.gov/pubmed/35723065 http://dx.doi.org/10.1111/cas.15466 |
Ejemplares similares
-
Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model
por: Okada, Ryuhei, et al.
Publicado: (2021) -
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy
por: Furumoto, Hideyuki, et al.
Publicado: (2022) -
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model
por: Furusawa, Aki, et al.
Publicado: (2022) -
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
por: Inagaki, Fuyuki F., et al.
Publicado: (2022) -
Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
por: Kato, Takuya, et al.
Publicado: (2022)